CoreWeave's Acquisition of Core Scientific Raises Questions on CRWV Stock Value

CoreWeave (CRWV) plans to buy Core Scientific (CORZ) for $9 billion, boosting its presence in the data center infrastructure market. The acquisition could lead to $500 million in annual cost savings by 2027. However, Macquarie analysts are skeptical, maintaining a price target of $65, reflecting a potential 59% downside from current levels.

Despite the acquisition, CoreWeave stock is up 220% since its IPO. The deal would provide CoreWeave with 1.3 GW of power capacity and streamline operations. However, with a price-sales ratio of over 28x, CRWV shares are seen as overvalued by Wall Street experts, who predict a potential 50% downside from the current price.

While the Core Scientific acquisition could be 5% accretive to earnings per share, analysts believe the current valuation of CoreWeave already accounts for this potential upside. Despite a “Moderate Buy” consensus rating on CRWV shares, the mean target price of $82 suggests a nearly 50% downside from the current price.

Read more at Yahoo Finance: CoreWeave Seals the Deal to Buy Core Scientific. Should You Buy CRWV Stock Here?